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Metabolic syndrome (MetS) is a cluster of various clinical cardiovascular risk fac-
tor and causes metabolic and structural cardiomyocytes damage. Our previous study 
showed that MetS increases cardiomyocytes stress chaperones (1). In this work we 
aimed to investigate if patients with MetS showed alteration of surface, mitochondria 
and inflammatory markers in atrium cardiomyocytes.
Atrium samples from MetS patients with stable angina, undergoing coronary 
artery bypass graft surgery were used. Samples from matched age subjects without 
MetS and no smokers, undergoing cardiac surgery for other reasons, were used as 
controls. The samples, obtained before cardioplegia, were fixed and processed for 
Caveolin 1 (Cav1), MURC, Citrate Synthase (CS), SIRT3, SOD1, IL6-10, iNOS and 
eNOS by immunohistochemistry. Compared to controls, in cardiomyocytes from 
MetS patients decreased the expression of Cav1, MURC, SIRT3, IL10 and eNOS, 
whereas increased the expression of CS, SOD1, IL6, iNOS.
Cardiomyocytes from MetS patients present an evident inflammatory chronic 
state, that alters the Cav1-MURC expression. These alterations could reduce the 
exchange functions of sarcolemma so impairing the contractile capacity associated 
with mitochondrial impairment. We speculate that these damages could induce anti-
oxidant SOD1 over-expression to rescue the cells. All these results, first from human 
heart, suggest that MetS induces severe enzymatic disregulation in atrium cardiomy-
ocytes that may predispose to cardiac surgery complications.
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